GSK Settles Zantac Cancer Lawsuit Set to Go to Trial Next Month
American depositary receipts of GSK jumped after the U.K.-based biopharma company said it had reached a settlement in a lawsuit accusing the firm’s discontinued heartburn medicine, Zantac, of causing cancer.
( 1
min )